A malaria vaccine adjuvant based on recombinant antigen binding to liposomes

Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications

van Rooijen, N., & Sanders, A. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90012-4 · Cited by 1,763

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

Cunningham, A. L., Lal, H., Kovac, M., Chlibek, R., Hwang, S.-J., Díez-Domingo, J., Godeaux, O., Levin, M. J., McElhaney, J. E., Puig-Barberà, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603800 · Cited by 1,070

The origin and development of nonlymphoid tissue CD103+ DCs

Ginhoux, F., Liu, K., Helft, J., Bogunovic, M., Greter, M., Hashimoto, D., Price, J. G., Yin, N., Bromberg, J. S., Lira, S. A., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20091756 · Cited by 736

Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells

Edelson, B. T., Wumesh, K. C., Juang, R., Kohyama, M., Benoît, L. A., Klekotka, P. A., Moon, C., Albring, J. C., Ise, W., Michael, D. G., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091627 · Cited by 710

Effective Treatment of Cobalamin Deficiency With Oral Cobalamin

Kuzminski, A. M., Giacco, E. J. D., Allen, R. H., Stabler, S. P., & Lindenbaum, J. (1998) · Blood · doi:10.1182/blood.v92.4.1191 · Cited by 461

Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

Wu, Y., Ellis, R. D., Shaffer, D., Fontes, E., Malkin, E. M., Mahanty, S., Fay, M. P., Narum, D. L., Rausch, K. M., Miles, A. P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002636 · Cited by 447

Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes

Calabrό, S., Tortoli, M., Baudner, B. C., Pacitto, A., Cortese, M., O’Hagan, D. T., Gregorio, E. D., Seubert, A., & Wack, A. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.090 · Cited by 431

Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization

Brune, K. D., Leneghan, D. B., Brian, I. J., Ishizuka, A. S., Bachmann, M. F., Draper, S. J., Biswas, S., & Howarth, M. R. (2016) · Scientific Reports · doi:10.1038/srep19234 · Cited by 427

A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains

Kaslow, D. C., Quakyi, I. A., Syin, C., Raum, M. G., Keister, D. B., Coligan, J. E., McCutchan, T. F., & Miller, L. H. (1988) · Nature · doi:10.1038/333074a0 · Cited by 374

Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size

Allen, T. M., Austin, G. A., Chonn, A., Lin, L., & Lee, K. ‐. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90268-d · Cited by 344

Nanotechnology approaches for global infectious diseases

Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520

Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology

Cheng, K., Zhao, R., Li, Y., Qi, Y., Wang, Y., Zhang, Y., Qin, H., Qin, Y., Chen, L., Li, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22308-8 · Cited by 480

Second Near‐Infrared Photothermal Semiconducting Polymer Nanoadjuvant for Enhanced Cancer Immunotherapy

Li, J., Yu, X., Jiang, Y., He, S., Zhang, Y., Luo, Y., & Pu, K. (2020) · Advanced Materials · doi:10.1002/adma.202003458 · Cited by 342

Organic Semiconducting Pro‐nanostimulants for Near‐Infrared Photoactivatable Cancer Immunotherapy

Li, J., Cui, D. M., Huang, J., He, S., Yang, Z., Zhang, Y., Luo, Y., & Pu, K. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201906288 · Cited by 304

Controlling timing and location in vaccines

Irvine, D. J., Aung, A., & Silva, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.019 · Cited by 255

Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health

Fries, C. N., Curvino, E. J., Chen, J., Permar, S. R., Fouda, G. G., & Collier, J. H. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0739-9 · Cited by 254

Materials for Immunotherapy

Shields, C. W., Wang, L., Evans, M. A., & Mitragotri, S. (2019) · Advanced Materials · doi:10.1002/adma.201901633 · Cited by 194

Vaccine delivery systems toward lymph nodes

Ding, Y., Li, Z., Jaklenec, A., & Hu, Q. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113914 · Cited by 191

Advancements in prophylactic and therapeutic nanovaccines

Bhardwaj, P., Bhatia, E., Sharma, S., Ahamad, N., & Banerjee, R. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.03.020 · Cited by 156

Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy

Li, Y., Liu, J., Chen, Y., Weichselbaum, R. R., & Lin, W. (2024) · Advanced Science · doi:10.1002/advs.202310309 · Cited by 144

Emerging vaccine nanotechnology: From defense against infection to sniping cancer

Feng, C., Li, Y., Ferdows, B. E., Patel, D. N., Ouyang, J., Tang, Z., Kong, N., Chen, E., & Tao, W. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.021 · Cited by 131

Advances in Infectious Disease Vaccine Adjuvants

Fan, J., Jin, S., Gilmartin, L., Tóth, I., Hussein, W. M., & Stephenson, R. J. (2022) · Vaccines · doi:10.3390/vaccines10071120 · Cited by 118

Ultrasound technology and biomaterials for precise drug therapy

Zhao, Z., Saiding, Q., Cai, Z., Cai, M., & Cai, M. (2023) · Materials Today · doi:10.1016/j.mattod.2022.12.004 · Cited by 108

Liposomes as Adjuvants and Vaccine Delivery Systems

Tretiakova, D. S., & Vodovozova, E. L. (2022) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747822020076 · Cited by 109

SARS‐CoV‐2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination

Huang, W., Zhou, S., He, X., Chiem, K., Mabrouk, M. T., Nissly, R. H., Bird, I. M., Strauss, M., Sambhara, S. R., Ortega, J., et al. (2020) · Advanced Materials · doi:10.1002/adma.202005637 · Cited by 99

Biosynthesis of Self‐Assembled Proteinaceous Nanoparticles for Vaccination

Pan, C., Wu, J., Qing, S., Zhang, X., Zhang, L., Yue, H., Zeng, M., Wang, B., Yuan, Z., Qiu, Y., et al. (2020) · Advanced Materials · doi:10.1002/adma.202002940 · Cited by 93

Use of Protamine in Nanopharmaceuticals—A Review

Ruseska, I., Fresacher, K., Petschacher, C., & Zimmer, A. (2021) · Nanomaterials · doi:10.3390/nano11061508 · Cited by 93

Improving Cancer Immunotherapy Outcomes Using Biomaterials

Yan, S., Luo, Z., Li, Z., Wang, Y., Tao, J., Gong, C., & Liu, X. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202002780 · Cited by 90

Lipopolysaccharide lipid A: A promising molecule for new immunity-based therapies and antibiotics

García-Vello, P., Lorenzo, F. D., Zucchetta, D., Zamyatina, A., Castro, C. D., & Molinaro, A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107970 · Cited by 86

Photoactivatable Immunostimulatory Nanomedicine for Immunometabolic Cancer Therapy

Wu, W., Pu, Y., Zhou, B., Shen, Y., Gao, S., Zhou, M., & Shi, J. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c07872 · Cited by 81

Advanced technologies for the development of infectious disease vaccines

Gupta, A., Rudra, A., Reed, K., Langer, R., & Anderson, D. G. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01041-z · Cited by 87

Metal-based nano-vaccines for cancer immunotherapy

Li, J., Ren, H., & Zhang, Y. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214345 · Cited by 79

A Potent Cancer Vaccine Adjuvant System for Particleization of Short, Synthetic CD8+ T Cell Epitopes

He, X., Zhou, S., Huang, W., Seffouh, A., Mabrouk, M. T., Morgan, M. T., Ortega, J., Abrams, S. I., & Lovell, J. F. (2021) · ACS Nano · doi:10.1021/acsnano.0c07680 · Cited by 73

Soft materials as biological and artificial membranes

Tang, S., Davoudi, Z., Wang, G., Xu, Z., Rehman, T. U., Promiński, A., Tian, B., Bratlie, K. M., Peng, H., & Wang, Q. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00029b · Cited by 72

Nanocarrier system: An emerging strategy for bioactive peptide delivery

Zhang, X., Li, X., Zhao, Y., Zheng, Q., Wu, Q., & Yu, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1050647 · Cited by 63

Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria

Gujjari, L., Kalani, H., Pindiprolu, S. K. S. S., Arakareddy, B. P., & Yadagiri, G. (2022) · Parasite Epidemiology and Control · doi:10.1016/j.parepi.2022.e00244 · Cited by 62

Nanomaterial-Based Drug Delivery System Targeting Lymph Nodes

Cheng, Z., Que, H., Chen, L., Sun, Q., & Wei, X. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071372 · Cited by 60

Organic Semiconducting Pro‐nanostimulants for Near‐Infrared Photoactivatable Cancer Immunotherapy

Li, J., Cui, D. M., Huang, J., He, S., Yang, Z., Zhang, Y., Luo, Y., & Pu, K. (2019) · Angewandte Chemie · doi:10.1002/ange.201906288 · Cited by 56

Biomaterials as Tools to Decode Immunity

Eppler, H. B., & Jewell, C. M. (2019) · Advanced Materials · doi:10.1002/adma.201903367 · Cited by 53

Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment

Huang, W., Deng, B., Seffouh, A., Ortega, J., Long, C. A., Suresh, R. V., He, X., Miura, K., Lee, S., Wu, Y., et al. (2020) · npj Vaccines · doi:10.1038/s41541-020-0173-x · Cited by 53

Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses

McLeod, B., Mabrouk, M. T., Miura, K., Ravichandran, R., Kephart, S. M., Hailemariam, S., Pham, T., Semesi, A., Kucharska, I., Kundu, P., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.07.015 · Cited by 52

Bioresponsive Immunotherapeutic Materials

Han, J., Sheng, T., Zhang, Y., Cheng, H., Gao, J., Yu, J., & Gu, Z. (2023) · Advanced Materials · doi:10.1002/adma.202209778 · Cited by 52

Vaccine approaches for antigen capture by liposomes

Zhou, S., Luo, Y., & Lovell, J. F. (2023) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2274479 · Cited by 52

Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants

Lei, H., Alu, A., Yang, J., He, X., He, C., Ren, W., Chen, Z., Hong, W., Chen, L., He, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38066-8 · Cited by 49

Lyophilized, thermostable Spike or RBD immunogenic liposomes induce protective immunity against SARS-CoV-2 in mice

Mabrouk, M. T., Chiem, K., Rujas, E., Huang, W., Jahagirdar, D., Quinn, B., Nair, M. S., Nissly, R. H., Cavener, V. S., Boyle, N. R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj1476 · Cited by 47

Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25

McLeod, B., Miura, K., Scally, S. W., Bosch, A., Nguyen, N. T. K., Shin, H., Kim, D., Volkmuth, W., Rämisch, S., Chichester, J. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11980-6 · Cited by 45

Integrating Biomaterials and Immunology to Improve Vaccines Against Infectious Diseases

Yenkoidiok-Douti, L., & Jewell, C. M. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01255 · Cited by 42

Liposomes for malaria management: the evolution from 1980 to 2020

Memvanga, P. B., & Nkanga, C. I. (2021) · Malaria Journal · doi:10.1186/s12936-021-03858-0 · Cited by 45

Advanced Materials for SARS‐CoV‐2 Vaccines

Mabrouk, M. T., Huang, W., Martínez‐Sobrido, L., & Lovell, J. F. (2021) · Advanced Materials · doi:10.1002/adma.202107781 · Cited by 38

Long-acting vaccine delivery systems

Walvekar, P., Kumar, P., & Choonara, Y. E. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114897 · Cited by 39

Engineering Biomaterials to Direct Innate Immunity

Oakes, R. S., Froimchuk, E., & Jewell, C. M. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201800157 · Cited by 38

Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes

Federizon, J., Frye, A. M., Huang, W., Hart, T. M., He, X., Beltran, C., Marcinkiewicz, A. L., Mainprize, I. L., Wills, M. K. B., Lin, Y., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.10.073 · Cited by 38

HPV‐Associated Tumor Eradication by Vaccination with Synthetic Short Peptides and Particle‐Forming Liposomes

He, X., Zhou, S., Quinn, B., Jahagirdar, D., Ortega, J., Abrams, S. I., & Lovell, J. F. (2021) · Small · doi:10.1002/smll.202007165 · Cited by 37

A versatile supramolecular nanoadjuvant that activates NF-κB for cancer immunotherapy

Xu, Y., Wang, Y., Yang, Q., Liu, Z., Xiao, Z., Le, Z., Yang, Z., & Yang, C. (2019) · Theranostics · doi:10.7150/thno.34031 · Cited by 37

Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose

Huang, W., Deng, B., Mabrouk, M. T., Seffouh, A., Ortega, J., Long, C. A., Miura, K., Wu, Y., & Lovell, J. F. (2020) · Malaria Journal · doi:10.1186/s12936-020-03368-5 · Cited by 36

A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge

Sia, Z. R., He, X., Zhang, A., Ang, J. C., Shao, S., Seffouh, A., Huang, W., D’Agostino, M. R., Dereshgi, A. T., Sambhara, S. R., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025759118 · Cited by 35

mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response

Scaria, P. V., Roth, N., Schwendt, K., Muratova, O. V., Alani, N., Lambert, L., Barnafo, E. K., Rowe, C. G., Zaidi, I., Rausch, K. M., et al. (2024) · npj Vaccines · doi:10.1038/s41541-023-00783-y · Cited by 36

Bioactive metal-based nanomedicines for boosting anti-tumor immunity: Advance, challenge, and perspective

Pei, Z., Li, L., Yang, N., Sun, S., Jiang, N., & Cheng, L. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.215969 · Cited by 34

Targeting vaccines to dendritic cells by mimicking the processing and presentation of antigens in xenotransplant rejection

Wang, J., Zhang, Y., Jia, Y., Xing, H., Xu, F., Xia, B., Lai, W., Yuan, Y., Li, X., Shan, S., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01343-6 · Cited by 38

Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages

Huang, W., Mabrouk, M. T., Zhou, L., Baba, M., Tachibana, M., Torii, M., Takashima, E., Locke, E., Plieskatt, J. L., King, C. R., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03688-z · Cited by 34

A sweeter approach to vaccine design

Wilson, J. T. (2019) · Science · doi:10.1126/science.aav9000 · Cited by 33

Nanobiotechnological modules as molecular target tracker for the treatment and prevention of malaria: options and opportunity

Anamika, J., Vishwakarma, N., Gautam, L., Shrivastava, P., Vyas, S., & Vyas, S. P. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00770-z · Cited by 31

Application of liposomes in the treatment of infectious diseases

Suhaimi, N. A. A., Ahmad, S., Husna, S. M. N., Sarmiento, M. E., Acosta, A., Norazmi, M. N., Ibrahim, J., Mohamud, R., & Kadir, R. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120734 · Cited by 28

Improving Cancer Immunotherapy Outcomes Using Biomaterials

Yan, S., Luo, Z., Li, Z., Wang, Y., Tao, J., Gong, C., & Liu, X. (2020) · Angewandte Chemie · doi:10.1002/ange.202002780 · Cited by 28

Engineered Nanoparticle Applications for Recombinant Influenza Vaccines

Sia, Z. R., Miller, M. S., & Lovell, J. F. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00383 · Cited by 26

An Engineered Biomimetic MPER Peptide Vaccine Induces Weakly HIV Neutralizing Antibodies in Mice

Shao, S., Huang, W., Lin, C., Hicar, M. D., LaBranche, C. C., Montefiori, D. C., & Lovell, J. F. (2019) · Annals of Biomedical Engineering · doi:10.1007/s10439-019-02398-8 · Cited by 25

Lyophilized, antigen-bound liposomes with reduced MPLA and enhanced thermostability

Mabrouk, M. T., Huang, W., Deng, B., Li-Purcell, N., Seffouh, A., Ortega, J., Atilla‐Gokcumen, G. E., Long, C. A., Miura, K., & Lovell, J. F. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119843 · Cited by 24

Immunization with short peptide particles reveals a functional CD8+ T-cell neoepitope in a murine renal carcinoma model

He, X., Zhou, S., Dolan, M., Shi, Y., Wang, J., Quinn, B., Jahagirdar, D., Huang, W., Tsuji, M., Пили, Р., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003101 · Cited by 24

Drug‐phospholipid conjugate nano‐assembly for drug delivery

Zhao, D., Zhang, Y., Wang, F., Kaewmanee, R., Cui, W., Wu, T., & Du, Y. (2024) · Smart Medicine · doi:10.1002/smmd.20240053 · Cited by 23

Antigens and adjuvants co-stabilized Pickering emulsions amplify immune responses of subunit vaccines

Guo, Z., Guo, C., Song, Y., He, C., He, P., Wu, F., Tang, X., Xu, Y., Ou, Y., Hu, R., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.009 · Cited by 23

Manganese-Driven Plasmid Nanofibers Formed In Situ for Cancer Gene Delivery and Metalloimmunotherapy

Li, J., Yang, R., Zhang, C., Lovell, J. F., & Zhang, Y. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c18511 · Cited by 21

The sixth revolution in pediatric vaccinology: immunoengineering and delivery systems

Soni, D., Bobbala, S. K. R., Li, S., Scott, E. A., & Dowling, D. J. (2020) · Pediatric Research · doi:10.1038/s41390-020-01112-y · Cited by 21

One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects

Lovell, J. F., Miura, K., Baik, Y. O., Lee, C., Lee, J.-Y., Park, Y.-S., Hong, I., Lee, J. H., Kim, T., Seo, S. H., et al. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.11.004 · Cited by 20

Organic coordination nanoparticles for phototheranostics

Ren, H., Li, J., Lovell, J. F., & Zhang, Y. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215634 · Cited by 20

Imitation of nature: Bionic design in the study of particle adjuvants

Wu, J., & Ma, G. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.004 · Cited by 20

Liposomes for Intra-Articular Analgesic Drug Delivery in Orthopedics: State-of-Art and Future Perspectives. Insights from a Systematic Mini-Review of the Literature

Cipollaro, L., Trucillo, P., Bragazzi, N. L., Porta, G. D., Reverchon, E., & Maffulli, N. (2020) · Medicina · doi:10.3390/medicina56090423 · Cited by 19

Intranasal Immunization with Liposome-Displayed Receptor-Binding Domain Induces Mucosal Immunity and Protection against SARS-CoV-2

Huang, W., Chiem, K., Martínez‐Sobrido, L., & Lovell, J. F. (2022) · Pathogens · doi:10.3390/pathogens11091035 · Cited by 20

A metalloprotein nanoparticle scaffold co-delivers antigens and adjuvants with metal-enhanced STING activation for vaccination preventing viral infections

Li, J., Qiu, Q., Ren, H., Zhang, J., Zhang, C., Liu, G., Sun, B., Zhang, Y., Lovell, J. F., & Zhang, Y. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102156 · Cited by 18

Experimental and Computational Observations of Immunogenic Cobalt Porphyrin Lipid Bilayers: Nanodomain-Enhanced Antigen Association

Federizon, J., Feugmo, C. G. T., Huang, W., He, X., Miura, K., Razi, A., Ortega, J., Karttunen, M., & Lovell, J. F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010098 · Cited by 18

Licensed liposomal vaccines and adjuvants in the antigen delivery system

Krasnopolsky, Y., & Pylypenko, D. (2022) · Biotechnologia · doi:10.5114/bta.2022.120709 · Cited by 21

Chromium Nanoparticles Improve Macrophage and T Cell Infiltration for Cancer Immunotherapy

Liu, Q., Sun, Z., Duo, Y., Yin, L., Lv, K., Yue, L., Meng, Q., Nie, D., Chen, J., Luo, D., et al. (2023) · ACS Materials Letters · doi:10.1021/acsmaterialslett.2c01136 · Cited by 17

Adjuvanted nanoliposomes displaying six hemagglutinins and neuraminidases as an influenza virus vaccine

Sia, Z. R., Roy, J., Huang, W., Song, Y., Zhou, S., Luo, Y., Li, Q., Arpin, D., Kutscher, H. L., Ortega, J., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101433 · Cited by 17

Malaria transmission-blocking vaccines: wheat germ cell-free technology can accelerate vaccine development

Miura, K., Tachibana, M., Takashima, E., Morita, M., Kanoi, B. N., Nagaoka, H., Baba, M., Torii, M., Ishino, T., & Tsuboi, T. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1674145 · Cited by 17

Nanoparticles in Subunit Vaccines: Immunological Foundations, Categories, and Applications

Liang, J., Yao, L., Liu, Z., Chen, Y., Lin, Y., & Tian, T. (2024) · Small · doi:10.1002/smll.202407649 · Cited by 17

Display of malaria transmission-blocking antigens on chimeric duck hepatitis B virus-derived virus-like particles produced in Hansenula polymorpha

Wetzel, D., Chan, J.-A., Suckow, M., Barbian, A., Weniger, M., Jenzelewski, V., Reiling, L., Richards, J. S., Anderson, D. A., Kouskousis, B. P., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221394 · Cited by 16

Advances of Nanotechnology Toward Vaccine Development Against Animal Infectious Diseases

Wang, X., Gao, X., Wang, L., Lin, J., & Liu, Y. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202305061 · Cited by 16

Influenza Virus Infects and Depletes Activated Adaptive Immune Responders

Bohannon, C. D., Ende, Z. S., Cao, W., Mboko, W. P., Ranjan, P., Kumar, A., Mishina, M., Amoah, S., Gangappa, S., Mittal, S. K., et al. (2021) · Advanced Science · doi:10.1002/advs.202100693 · Cited by 15

An In Vivo Screen to Identify Short Peptide Mimotopes with Enhanced Antitumor Immunogenicity

He, X., Zhou, S., Quinn, B., Jahagirdar, D., Ortega, J., Long, M. D., Abrams, S. I., & Lovell, J. F. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0332 · Cited by 15

Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza Virus

Sia, Z. R., Chiem, K., Huang, W., Seffouh, A., Dereshgi, A. T., Hogan, T., Ortega, J., Davidson, B. A., Martínez‐Sobrido, L., & Lovell, J. F. (2022) · Journal of Virology · doi:10.1128/jvi.01006-22 · Cited by 15

Expression and purification optimization of an N-terminal Pfs230 transmission-blocking vaccine candidate

Lee, S., Plieskatt, J. L., Krishnan, S., Raina, M., Harishchandra, R., & King, C. R. (2019) · Protein Expression and Purification · doi:10.1016/j.pep.2019.04.001 · Cited by 15

Opportunities and Challenges for Nanomaterials as Vaccine Adjuvants

Li, Z., Chen, P., Qu, A., Sun, M., Xu, L., Xu, C., Hu, S., & Kuang, H. (2025) · Small Methods · doi:10.1002/smtd.202402059 · Cited by 14

Bacillus subtilis spores as delivery system for nasal Plasmodium falciparum circumsporozoite surface protein immunization in a murine model

de Almeida, M. E. M., Alves, K. C. S., de Vasconcelos, M. G. S., Pinto, T. S., Glória, J. C., Chaves, Y. O., Neves, W. L. L., Tarragô, A. M., Neto, J. N. D. S., Astolfi‐Filho, S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05344-2 · Cited by 14

Copper indium selenium nanomaterials for photo-amplified immunotherapy through simultaneously enhancing cytotoxic T lymphocyte recruitment and M1 polarization of macrophages

Chen, Y.-N., Yang, Y., He, X., Liu, X., Yu, P., Liu, R., Wei, L., Zhang, B., Zou, T., Liu, H., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.09.033 · Cited by 13

Mechanochemical insertion of cobalt into porphyrinoids using Co 2 (CO) 8 as a cobalt source

Damunupola, D., Chaudhri, N., Atoyebi, A. O., & Brückner, C. (2020) · Green Chemistry · doi:10.1039/d0gc01010c · Cited by 13

Chloroform-Injection (CI) and Spontaneous-Phase-Transition (SPT) Are Novel Methods, Simplifying the Fabrication of Liposomes with Versatile Solution to Cholesterol Content and Size Distribution

Khan, M. I., Ahmed, N., Umer, M. F., Riaz, A., Ahmad, N. M., & Khan, G. M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111065 · Cited by 13

Biomimic strategies for modulating the interaction between particle adjuvants and antigen-presenting cells

Wu, J., & Ma, G. (2020) · Biomaterials Science · doi:10.1039/c9bm02098e · Cited by 13

Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis

Huang, W., EBERLE, K. E., Rosario-Colon, J., Lovell, J. F., & Xin, H. (2024) · mSphere · doi:10.1128/msphere.00189-24 · Cited by 12

A landscape review of malaria vaccine candidates in the pipeline

Tajudeen, Y. A., Oladipo, H. J., Yusuff, S. I., Abimbola, S. O., Abdulkadir, M., Oladunjoye, I. O., Omotosho, A. O., Egbewande, O. M., Shittu, H. D., Yusuf, R. O., et al. (2024) · Tropical Diseases Travel Medicine and Vaccines · doi:10.1186/s40794-024-00222-3 · Cited by 13

A pentavalent peptide vaccine elicits Aβ and tau antibodies with prophylactic activity in an Alzheimer’s disease mouse model

Song, Y., Dai, C., Shinohara, M., Tung, Y. C., Zhou, S., Huang, W., Seffouh, A., Luo, Y., Willadsen, M., Jiao, Y., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.08.028 · Cited by 13

Metalloparticle‐Engineered Pickering Emulsion Displaying AAV‐Vectored Vaccine for Enhancing Antigen Expression and Immunogenicity Against Pathogens

Guo, Z., Wu, F., Guo, C., Hu, R., Ou, Y., Zhu, Y., Luo, S., Song, Y., He, P., He, C., et al. (2025) · Advanced Materials · doi:10.1002/adma.202412627 · Cited by 16

SARS‐CoV‐2 Protein Nanoparticle Vaccines Formed In Situ From Lyophilized Lipids

Jiao, Y., Huang, W., Chiem, K., Song, Y., Sun, J., Chothe, S. K., Zhou, S., Luo, Y., Mabrouk, M. T., Ortega, J., et al. (2023) · Small · doi:10.1002/smll.202304534 · Cited by 11

Antibody induction in mice by liposome-displayed recombinant enterotoxigenic Escherichia coli (ETEC) colonization antigens

Zhou, S., Yu, K. O. A., Mabrouk, M. T., Jahagirdar, D., Huang, W., Guerra, J. A., He, X., Ortega, J., Poole, S., Hall, E. R., et al. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.03.001 · Cited by 11

Antigen Engineering Approaches for Lyme Disease Vaccines

Federizon, J., Lin, Y., & Lovell, J. F. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00167 · Cited by 11

Materials‐based vaccines for infectious diseases

Yang, B., & Wang, H. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1824 · Cited by 10

A broadly applicable protein-polymer adjuvant system for antiviral vaccines

Wang, C., Geng, Y., Wang, H., Ren, Z., Hou, Q., Fang, A., Wu, Q. D., Wu, L., Shi, X., Zhou, M., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00076-4 · Cited by 9

CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits

Koornneef, A., Vanshylla, K., Hardenberg, G., Rutten, L., Strokappe, N. M., Tolboom, J. T. B. M., Vreugdenhil, J., Boer, K. F.-D., Perkasa, A., Blokland, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47492-1 · Cited by 9

Poor CD4+ T Cell Immunogenicity Limits Humoral Immunity to P. falciparum Transmission-Blocking Candidate Pfs25 in Humans

Zaric, M., Marini, A., Nielsen, C. M., Gupta, G., Mekhaiel, D., Pham, T., Elias, S. C., Taylor, I. J., de Graaf, H., Payne, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.732667 · Cited by 9

Position‐Scanning Peptide Libraries as Particle Immunogens for Improving CD8+ T‐Cell Responses

He, X., Zhou, S., Quinn, B., Huang, W., Jahagirdar, D., Vega, M., Ortega, J., Long, M. D., Ito, F., Abrams, S. I., et al. (2021) · Advanced Science · doi:10.1002/advs.202103023 · Cited by 8

Nanotoxicological profiles of clinically approved nanoplatforms

Nkanga, C. I. (2023) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-023-00458-6 · Cited by 9

Malaria vaccine approaches leveraging technologies optimized in the COVID-19 era

Kanoi, B. N., Maina, M., Likhovole, C., Kobia, F., & Gitaka, J. (2022) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2022.988665 · Cited by 11

Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment

Huang, W., Deng, B., Seffouh, A., Ortega, J., Long, C. A., Suresh, R. V., He, X., Miura, K., Lee, S., Wu, Y., et al. (2020) · npj Vaccines · doi:10.1038/s41541-020-0173-x · Cited by 53

Experimental and Computational Observations of Immunogenic Cobalt Porphyrin Lipid Bilayers: Nanodomain-Enhanced Antigen Association

Federizon, J., Feugmo, C. G. T., Huang, W., He, X., Miura, K., Razi, A., Ortega, J., Karttunen, M., & Lovell, J. F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010098 · Cited by 18

Liposomes loaded with P. falciparum merozoite-derived proteins are highly immunogenic and produce invasion-inhibiting and anti-toxin antibodies

Fotoran, W. L., Santangelo, R., Medeiros, M. M., Colhone, M. C., Ciancaglini, P., Barboza, R., Marinho, C. R. F., Stábeli, R. G., & Wunderlich, G. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.045 · Cited by 16

TLR-adjuvanted nanoparticle vaccines differentially influence the quality and longevity of responses to malaria antigen Pfs25

Thompson, E. A., Ols, S., Miura, K., Rausch, K. M., Narum, D. L., Spångberg, M., Juraska, M., Wille-Reece, U., Weiner, A. J., Howard, R. F., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120692 · Cited by 73

Lyophilized, antigen-bound liposomes with reduced MPLA and enhanced thermostability

Mabrouk, M. T., Huang, W., Deng, B., Li-Purcell, N., Seffouh, A., Ortega, J., Atilla‐Gokcumen, G. E., Long, C. A., Miura, K., & Lovell, J. F. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119843 · Cited by 24